Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

EVP, Corporate Affairs & GC

Chief Medical Officer

Chief Commercial Officer

Chief Financial Officer

SVP, Controllership

Chairman & CEO

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc. and Tentarix Biotherapeutics Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need i...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-05-08	Premium	acquired	Premium	Premium	Premium	-
2024-04-25	Premium	acquired	Premium	Premium	Premium	EVP, Corporate Affairs & GC
2024-04-25	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Corporate Affairs & GC
2024-04-01	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Corporate Affairs & GC
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	EVP, Corporate Affairs & GC
2024-03-10	Premium	acquired	Premium	Premium	Premium	SVP, Controllership
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Controllership
2024-03-10	Premium	sold (taxes)	Premium	Premium	Premium	Chairman & CEO
2024-03-10	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-10	Premium	acquired	Premium	Premium	Premium	Chairman & CEO
2024-02-29	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-28	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-02-02	Premium	acquired	Premium	Premium	Premium	-
2024-01-31	Premium	sold (taxes)	Premium	Premium	Premium	Chairman & CEO

GILD - Gilead Sciences Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for GILD